(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.
Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related T...
Buyer
NEWCASTLE UNIVERSITY
Value
£30,000
Published
30 Sept 2022
Closes
19 Aug 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Services
Contract starts
25 Sept 2022
Contract ends
30 Jun 2023
CPV classifications
79400000
Business and management consultancy and related services
Lots
Lot default (NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.
£30,000
Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs...
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
30 Sept 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.